Apr 30, 2012
4:225
For every 225 shares held, investors received 4.
The split itself did not change the total investment value.
TG Therapeutics, Inc. (GETTEX:NKB2) operates in the Pharmaceuticals: major industry.
TG Therapeutics, Inc. company overviewTG Therapeutics, Inc.'s most recent stock split was on April 30, 2012. It was a 4-for-225 reverse split, so shareholders received 4 shares for every 225 they held.
TG Therapeutics, Inc. (GETTEX:NKB2) has split its stock 3 times: a 1-for-5 reverse split on September 25, 2003, a 1-for-50 reverse split on July 14, 2011, and a 4-for-225 reverse split on April 30, 2012.
TG Therapeutics, Inc. has split its stock 3 times. This history records 3 reverse splits between September 25, 2003 and April 30, 2012.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In TG Therapeutics, Inc.'s 4-for-225 reverse split on April 30, 2012, every 225 shares became 4 shares. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
TG Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on April 30, 2012, 14 years ago. Companies announce splits in advance, and any new GETTEX:NKB2 split will appear on this page.